Systemic therapy of advanced non-small cell lung cancer: Major-developments of the last 5-years
Cufer, Tanja, Ovcaricek, Tanja, O’Brien, Mary E.R
Published in European journal of cancer (1990) (01.04.2013)
Published in European journal of cancer (1990) (01.04.2013)
Get full text
Journal Article
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data
Rossi, Antonio, Dr, Chiodini, Paolo, PhD, Sun, Jong-Mu, MD, O'Brien, Mary E R, MD, von Plessen, Christian, MD, Barata, Fernando, MD, Park, Keunchil, Prof, Popat, Sanjay, FRCP, Bergman, Bengt, MD, Parente, Barbara, MD, Gallo, Ciro, Prof, Gridelli, Cesare, MD, Perrone, Francesco, MD, Di Maio, Massimo, MD
Published in The lancet oncology (01.10.2014)
Published in The lancet oncology (01.10.2014)
Get full text
Journal Article
Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
Collins, Dearbhaile Catherine, Sundar, Raghav, Constantinidou, Anastasia, Dolling, David, Yap, Timothy Anthony, Popat, Sanjay, O'Brien, Mary E, Banerji, Udai, de Bono, Johann Sebastian, Lopez, Juanita Suzanne, Tunariu, Nina, Minchom, Anna
Published in BMC cancer (09.12.2020)
Published in BMC cancer (09.12.2020)
Get full text
Journal Article
Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer
O'BRIEN, Mary E. R, CIULEANU, Tudor-Eliade, TSEKOV, Hristo, SHPARYK, Yaroslav, CUCEVIA, Branka, JUHASZ, Gabor, THATCHER, Nicholas, ROSS, Graham A, DANE, Graham C, CROFTS, Theresa
Published in Journal of clinical oncology (01.12.2006)
Published in Journal of clinical oncology (01.12.2006)
Get full text
Journal Article
Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for Chemonaïve Patients with Malignant Pleural Mesothelioma: Results of the International Expanded Access Program
Santoro, Armando, O'Brien, Mary E., Stahel, Rolf A., Nackaerts, Kristiaan, Baas, Paul, Karthaus, Meinolf, Eberhardt, Wilfried, Paz-Ares, Luis, Sundstrom, Stein, Liu, Yushan, Ripoche, Veronique, Blatter, Johannes, Visseren-Grul, Carla M., Manegold, Christian
Published in Journal of thoracic oncology (01.07.2008)
Published in Journal of thoracic oncology (01.07.2008)
Get full text
Journal Article
Overcoming CYP1A1/1A2 Mediated Induction of Metabolism by Escalating Erlotinib Dose in Current Smokers
HUGHES, Andrew N, O'BRIEN, Mary E. R, PRICE, Allan, PETTY, W. Jeffrey, CHICK, Jonathan B, RANKIN, Elaine, WOLL, Penella J, DUNLOP, David, NICOLSON, Marianne, BOINPALLY, Ramesh, WOLF, Julie
Published in Journal of clinical oncology (10.03.2009)
Published in Journal of clinical oncology (10.03.2009)
Get full text
Journal Article
Lung Adenocarcinoma with Concurrent Exon 19 EGFR Mutation and ALK Rearrangement Responding to Erlotinib
Popat, Sanjay, Vieira de Araújo, Alexandra, Min, Toon, Swansbury, John, Dainton, Melissa, Wotherspoon, Andrew, Lim, Eric, Nicholson, Andrew G., O'Brien, Mary E.R.
Published in Journal of thoracic oncology (01.11.2011)
Published in Journal of thoracic oncology (01.11.2011)
Get full text
Journal Article
Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
Collins, Dearbhaile Catherine, Sundar, Raghav, Constantinidou, Anastasia, Dolling, David, Yap, Timothy Anthony, Popat, Sanjay, O'Brien, Mary E, Banerji, Udai, de Bono, Johann Sebastian, Lopez, Juanita Suzanne, Tunariu, Nina, Minchom, Anna
Published in BMC cancer (08.03.2021)
Published in BMC cancer (08.03.2021)
Get full text
Journal Article
nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
Gridelli, Cesare, Chen, Tianlei, Ko, Amy, O'Brien, Mary E, Ong, Teng Jin, Socinski, Mark A, Postmus, Pieter E
Published in Drug design, development and therapy (01.01.2018)
Published in Drug design, development and therapy (01.01.2018)
Get full text
Journal Article
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)
O’Brien, Mary E.R, Gaafar, Rabab M, Popat, Sanjay, Grossi, Francesco, Price, Allan, Talbot, Denis C, Cufer, Tanja, Ottensmeier, Christian, Danson, Sarah, Pallis, Athanasios, Hasan, Baktiar, Van Meerbeeck, Jan P, Baas, Paul
Published in European journal of cancer (1990) (01.09.2013)
Published in European journal of cancer (1990) (01.09.2013)
Get full text
Journal Article
Establishing an EGFR mutation screening service for non-small cell lung cancer – Sample quality criteria and candidate histological predictors
Leary, Alexandra F, Castro, David Gonzalez de, Nicholson, Andrew G, Ashley, Sue, Wotherspoon, Andrew, O’Brien, Mary E.R, Popat, Sanjay
Published in European journal of cancer (1990) (01.01.2012)
Published in European journal of cancer (1990) (01.01.2012)
Get full text
Journal Article
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma
Blayney, Jaine K, Ceresoli, Giovanni L, Castagneto, Bruno, O’Brien, Mary E.R, Hasan, Baktiar, Sylvester, Richard, Rudd, Robin, Steele, Jeremy, Busacca, Sara, Porta, Camillo, Mutti, Luciano, O’Byrne, Kenneth J, Scullin, Paula, Gaafar, Rabab, Baas, Paul, Van Meerbeeck, Jan, Fennell, Dean A
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation
Hasan, Baktiar, Greillier, Laurent, Pallis, Athanasios, Menis, Jessica, Gaafar, Rabab, Sylvester, Richard, Fennell, Dean A, Baas, Paul, Surmont, Veerle, Van Meerbeeck, Jan P, O’brien, Mary E.R
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
How do lung cancer specialists follow their patients with stage III non-small cell lung cancer (NSCLC) after definitive treatment? – A short report
Yumuk, Perran Fulden, Mohammed, Nazia, Maat, Alexander P.W.M, Fink, Christian, Marchal, Benedicte, O’Brien, Mary E.R
Published in European journal of cancer (1990) (01.09.2012)
Published in European journal of cancer (1990) (01.09.2012)
Get full text
Journal Article
Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit
Papadatos-Pastos, Dionysis, Roda, Desam, De Miguel Luken, Maria Jose, Petruckevitch, Ann, Jalil, Awais, Capelan, Marta, Michalarea, Vasiliki, Lima, Joao, Diamantis, Nikolaos, Bhosle, Jaishree, Molife, L. Rhoda, Banerji, Udai, de Bono, Johann S, Popat, Sanjay, O'Brien, Mary E.R, Yap, Timothy A
Published in European journal of cancer (1990) (01.04.2017)
Published in European journal of cancer (1990) (01.04.2017)
Get full text
Journal Article
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial
Kelly, Karen, Altorki, Nasser K, Eberhardt, Wilfried E E, O'Brien, Mary E R, Spigel, David R, Crinò, Lucio, Tsai, Chun-Ming, Kim, Joo-Hang, Cho, Eun Kyung, Hoffman, Philip C, Orlov, Sergey V, Serwatowski, Piotr, Wang, Jiuzhou, Foley, Margaret A, Horan, Julie D, Shepherd, Frances A
Published in Journal of clinical oncology (01.12.2015)
Published in Journal of clinical oncology (01.12.2015)
Get full text
Journal Article
Modest Reductions in Dose Intensity and Drug-Induced Neutropenia have No Major Impact on Survival of Patients with Non-small Cell Lung Cancer Treated with Platinum-Doublet Chemotherapy
Brunetto, Andre T., Carden, Craig P., Myerson, James, Faria, Ana Luisa, Ashley, Sue, Popat, Sanjay, O'Brien, Mary E.R.
Published in Journal of thoracic oncology (01.09.2010)
Published in Journal of thoracic oncology (01.09.2010)
Get full text
Journal Article
Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer
von Pawel, Joachim, Jotte, Robert, Spigel, David R, O'Brien, Mary E R, Socinski, Mark A, Mezger, Jörg, Steins, Martin, Bosquée, Léon, Bubis, Jeffrey, Nackaerts, Kristiaan, Trigo, José M, Clingan, Philip, Schütte, Wolfgang, Lorigan, Paul, Reck, Martin, Domine, Manuel, Shepherd, Frances A, Li, Shaoyi, Renschler, Markus F
Published in Journal of clinical oncology (10.12.2014)
Published in Journal of clinical oncology (10.12.2014)
Get full text
Journal Article
Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and Prognosis
Cook, Gary J R, O'Brien, Mary E, Siddique, Muhammad, Chicklore, Sugama, Loi, Hoi Y, Sharma, Bhupinder, Punwani, Ravi, Bassett, Paul, Goh, Vicky, Chua, Sue
Published in Radiology (01.09.2015)
Published in Radiology (01.09.2015)
Get full text
Journal Article